Industry Ready To Embrace Digitalization, Says IGBA

Chair Sudarshan Jain Confident Biosimilars Will Broaden Access For Chronic Diseases

IGBA chair Sudarshan Jain has indicated that "companies are undergoing the change towards digital health," in the second part of an exclusive interview with Generics Bulletin in which Jain and IGBA secretary general Suzette Kox talk about the pandemic-driven shift towards digitalization and computerization.

Sudarshan Jain
IGBA chair Jain Sudarshan Jain talks about the importance of digitalization, telemedicine and digital health • Source: IGBA

“We are entering into a digital model today,” said Sudarshan Jain, chair of the IGBA and secretary general of the Indian Pharmaceutical Alliance, in the second part of an exclusive interview with Generics Bulletin, as he indicated that “in fact, the commercial models of all the companies are undergoing the change towards digital health.”

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Biosimilars

More from Products